DICE Therapeutics, Inc. Profile Avatar - Palmy Investing

DICE Therapeutics, Inc.

DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulat…
Biotechnology
US, South San Francisco [HQ]
DICE/Leadership and Strategy

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of DICE's Analysis
CIK: 1645569 CUSIP: 23345J104 ISIN: US23345J1043 LEI: - UEI: -
Secondary Listings
DICE has no secondary listings inside our databases.